Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience.

Since the start of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, several treatments have been proposed to cure coronavirus disease 2019 (COVID-19) and prevent it. Molnupiravir is a ribonucleoside prodrug of N-hydroxycytidine with an in vitro and in vivo activity against SARS-CoV-2. We conducted a retrospective cohort study that included all people treated with molnupiravir between January 10, 2022, and March 31, 2022, at the University Hospital of Sassari. Molnupiravir was prescribed, according to the Italian Agency of Drug indications, to patients with recent symptom onset (≤5 days), no need for oxygen supplementation, and with a high risk of disease progression for the presence of chronic diseases. We included 192 people with a mean age of 70.4 ± 15.4 years, with 144 (75%) patients over 60 years. During the follow-up, 20 (10.4%) patients showed a disease progression. At the multivariate analysis, older age, having neurological disease, having dyspnea at the onset of the symptoms, and acquiring SARS-CoV-2 infection during hospital admission were associated with an increased risk of progression. In contrast, an early start of treatment was associated with a reduced risk of disease progression. Molnupiravir was also extremely safe since 13 (6.8%) adverse events were reported, with only one interruption. Our study shows that monlupiravir confirmed its efficacy and safety in a real-life cohort that included a high percentage of elderly people with a high comorbidity burden.

Pseudoaneurysm of the mitral-aortic intervalvular fibrosa presenting after chest trauma and diagnosed by cardiac magnetic resonance: a case report.

INTRODUCTION: Annular subvalvular pseudoaneurysm is a rare example of left ventricle aneurysm described predominantly in young African people. These aneurysms are divided into two different types, namely, submitral or subaortic, with subaortic being the less frequent kind. The subaortic type is most often localized in the mitral-aortic intervalvular fibrosa. To the best of our knowledge, this is the first report of a mitral-aortic intervalvular fibrosa pseudoaneurysm associated with coarctation of the aorta, anomalous pulmonary venous return, bicuspid aortic valve and patent ductus arteriosus diagnosed by cardiovascular magnetic resonance. CASE PRESENTATION: We report the case of a 15-year-old African-American boy with a history of mild chest trauma who underwent echocardiographic evaluation as part of an out-patient work up. The echocardiogram was suspicious for the presence of mitral-aortic intervalvular fibrosa pseudoaneurysm and cardiovascular magnetic resonance was then performed to better characterize this finding. In addition to confirming the presence of the aneurysm, cardiovascular magnetic resonance also revealed coarctation of the aorta, a bicuspid aortic valve, and anomalous pulmonary venous return. CONCLUSION: In our case, cardiovascular magnetic resonance was helpful in: (a) making a definite diagnosis of mitral-aortic intervalvular fibrosa pseudoaneurysm and its borders, which was not clear with an echocardiogram examination; and (b) illustrating additional associated congenital anomalies including the anomalous pulmonary venous return.

Alteraçöes cardíacas na síndrome da imunodeficiência adquirida. Estudo prospectivo em vinte e um pacientes adultos com correlaçäo clinicopatológica / Cardiac abnormalities in the acquired immunodeficiency syndrome. A prospective study with a clinical-pathological correlation in twenty-one adult patient

Objetivo - Avaliar, as alterações cardíacas e sua evolução no decurso da síndrome da imunodeficiência adquirida e realizar correlação de dados clínicos e patológicos. Métodos - Foram estudados, prospectivamente, 21 pacientes entre 19 e 42 anos, (4 mulheres) internados com diagnóstico da síndrome da imunodeficiência adquirida e acompanhados até o óbito. Além dos exames de rotina, foram feitos ECG e ecocardiograma a cada 6 meses. Após o óbito, realizou-se estudo macro e microscópico. Resultados - As indicações mais freqüentes de internação foram: diarréia ou pneumonias de repetição, tuberculose, toxoplasmose ou sarcoma de Kaposi. Na avaliação cardíaca, mais freqüentemente, foram encontrados pericardite aguda ou crônica (42 por cento) e miocardiopatia dilatada (19 por cento). Quatro casos tiveram como causa mortis disfunções cardíacas, respectivamente, endocardite bacteriana, pericardite com derrame, miocardite bacteriana e infecção por Toxoplasma gondii. Conclusão - Algumas alterações cardíacas graves levaram ao óbito. Na maioria, houve boa correlação entre dados clínicos e anatomopatológicos. Avaliação cardíaca foi importante mesmo nos casos assintomáticos para se detectar alterações precoces e tratá-las convenientemente.